BioSpace News Archive

BioMidwest

American Physical Society (APS) Endorses ‘Virtual March Meeting’ Site for Knowledge Sharing after Show Cancellation

Organizers of the APS March Meeting, the world’s largest physics event, partner with physicists who developed free site after coronavirus-induced cancellation

March 10, 2020
·
4 min read
Deals

Rockwell Medical Acknowledges Receipt of Communications from Medical Resource Acquisition Group

Rockwell Medical, Inc. issued the following statement in response to communications publicly disseminated yesterday by an entity named “Medical Resource Acquisition Group LLC”, which purports to be a Rockwell Medical stockholder.

March 10, 2020
·
2 min read
Business

Trillium Therapeutics Reports Annual Financial and Operating Results

Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today reported financial and operating results, including an update on its transformation program, for the year ended December 31, 2019.

March 10, 2020
·
7 min read
Deals

ADVANZ PHARMA Corp. Limited to Voluntarily Delist from the Toronto Stock Exchange

ADVANZ PHARMA Corp. Limited announced that its board of directors has authorized the Company to apply to voluntarily delist its limited voting shares from the Toronto Stock Exchange..

March 10, 2020
·
7 min read
Business

Versant Ventures Strengthens Global Team and Discovery Engine Infrastructure

Versant Ventures announced several recent changes that expand and strengthen its global team, infrastructure and capabilities.

March 10, 2020
·
9 min read
Business

TScan Strengthens Board of Directors with Appointment of Douglas Fambrough, Ph.D.

TScan Therapeutics, a biopharmaceutical company focused on the development of T cell receptor (TCR) therapies which reprogram a patient’s own T cells to recognize shared cancer targets, today announced the appointment of Douglas Fambrough, Ph.D., to its board of directors (BoD).

March 10, 2020
·
2 min read
Drug Development

Asana BioSciences Announces Topical Sodium Channel Blocker ASN008 Achieves Positive Results for the Treatment of Pruritus in Atopic Dermatitis; Provides Update on JAK/SYK Inhibitor Gusacitinib in Phase 2 Studies for Chronic Hand Eczema and AD

Asana BioSciences announced positive topline results from a Phase 1b study evaluating the treatment of pruritus associated with atopic dermatitis for its topical sodium channel blocker, ASN008.

March 10, 2020
·
7 min read
Biotech Bay

Trianni, Inc. Announces License Agreement with Nkarta, Inc. for the Trianni Mouse®

Trianni, Inc. (“TRIANNI”) announced today that it has entered into a license agreement with Nkarta, Inc. (“NKARTA”) for the use of the Trianni Mouse®, a transgenic mouse R&D platform for the discovery of fully-human monoclonal antibodies, to support NKARTA’s antibody-based therapeutic discovery programs.

March 10, 2020
·
1 min read
Business

Moleculin Announces Dr. Hongbo Zhai Joins Science Advisory Board

To explore oncologic, dermatologic and viral opportunities for Moleculin’s drug portfolio in China

March 10, 2020
·
3 min read
Business

XOMA Reports Fourth Quarter and Full-Year 2019 Financial Results and Operating Highlights

XOMA Corporation (Nasdaq: XOMA) announced its fourth quarter and full-year 2019 financial results and business highlights.

March 10, 2020
·
12 min read